Test method for testing the integrity of a flexible packaging by diffusion of pressurized gas
A non-destructive gas diffusion method evaluates packaging integrity by measuring physical quantities to ensure sterility and prevent contamination, addressing the need for efficient integrity verification in flexible packaging.
Patent Information
- Application Number
- PCT/FR2026/050302
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-14
- Filing Date
- 2026-05-04
- Publication Date
- 2026-11-19
AI Technical Summary
There is a need for a non-destructive, efficient, and reliable method to verify the integrity of flexible packaging, particularly for sterilized medical devices, to prevent contamination during transport and use, while ensuring compliance with stringent sterility standards.
A non-destructive testing method involving the diffusion of pressurized gas through a porous film in the packaging, followed by evaluation of physical quantities such as displacement or thrust stresses, to detect integrity defects without altering the packaging.
The method provides a fast, economical, and ergonomic solution that ensures the integrity of flexible packaging, preventing contamination and allowing for both manual and automated processing of various quantities, while maintaining sterility.
Smart Images

Figure FR2026050302_19112026_PF_FP_ABST
Abstract
Description
[0001] DESCRIPTION
[0002] TITLE: Testing method for verifying the integrity of flexible packaging by pressurized gas diffusion
[0003] Technical field of the invention
[0004] The invention relates to a control method for checking the integrity of a flexible package.
[0005] It relates more specifically to a control process to check the integrity of a flexible package containing sterilized contents.
[0006] The invention also relates to a control installation implementing such a control method.
[0007] The invention finds a favorite, but not limited, application in the medical and pharmaceutical fields.
[0008] State of the art
[0009] As is well known in the medical and pharmaceutical fields, medical devices (such as needles, syringes, surgical instruments, etc.) are manufactured and sterilized in cleanrooms. To meet stringent sterilization requirements, these medical devices are also packaged in containers made from flexible materials that prevent the penetration of contaminants, such as bacteria, microbes, or particles. If the flexible packaging is made from a porous material, the pores may allow ambient air to enter, but their size is such that the penetration of contaminants is prohibited. In fact, the pore size of commonly used porous materials creates a barrier to particles larger than a limit value approximately equal to 1 µm.
[0010] According to Annex 1 of Volume 4 of Eudralex, the compilation of rules and regulations governing medicinal products in the European Union, when materials, equipment, articles, or auxiliary components are sterilized in sealed packages or containers, the packaging must be qualified to minimize the risk of contamination. In other words, the integrity of the packaging must be verified for each sterilized item before any use of the sterilized item.
[0011] In other words, it is mandatory and imperative to inspect the flexible packaging to ensure that it does not have any integrity defects. In this document, "integrity defect" means an opening larger than 100 µm in diameter, capable of allowing not only air (as is the case with a porous material as previously defined) but also, and more importantly, contaminants (such as bacteria, microbes, or particles) to pass into the flexible packaging, thus compromising the sterility of the contents. Such an integrity defect may appear in one of the films of the flexible packaging or at a seam between two films.
[0012] It is mandatory to verify the integrity of flexible packaging after transport, for example, from a first cleanroom where the contents were manufactured and then packaged to a second cleanroom where the contents are to be used. Indeed, if the integrity of the packaging has been compromised during transport, there is a high risk that the contents have been contaminated and a risk of contamination of the second cleanroom when the packaging is opened and / or through the passage of contaminants via the breach in integrity, which could then spread into the second cleanroom.
[0013] For practical reasons, it is important to avoid packaging integrity testing methods that involve destroying the flexible packaging. Indeed, destructive testing methods present numerous limitations for their implementation.
[0014] There is therefore a constant need to offer a non-destructive testing method to verify the integrity of flexible packaging that is practical and quick to implement, and has a high degree of reliability in detecting integrity defects.
[0015] Object of the invention
[0016] The present invention aims to provide a non-destructive testing solution for the integrity of a flexible package containing contents, particularly sterile contents.
[0017] This solution is designed to be implemented before the flexible packaging and its contents leave a first controlled atmosphere zone (e.g., a cleanroom) to verify the packaging's integrity before transport and / or before they enter a second controlled atmosphere zone (e.g., a cleanroom or an operating room) to prevent the risk of contamination of the second controlled atmosphere zone by the packaging or its contents. In a given application context, the inspection process is implemented before or after the transport of the flexible packaging and its contents to verify that they have not been damaged, i.e., that their integrity has not been compromised, before or during transport.
[0018] In particular, the aim of the invention is to provide a method and a non-destructive testing installation for checking the integrity of flexible packaging in order to verify the presence or absence of an integrity defect in the packaging, and which meets at least one of the following objectives:
[0019] - to offer a fast, economical, safe, ergonomic, simple and effective solution
[0020] - to offer a non-destructive testing method for the use of the packaging and its contents, providing flexibility in implementation, in particular by making it applicable by the manufacturer of the contents,
[0021] - to offer a manual or automatable solution allowing for the agile processing of small or large quantities,
[0022] - to avoid contamination of the inside of the packaging and its contents during the manufacturing process,
[0023] - to offer the possibility of setting up on a production line while respecting the cycle time of the line.
[0024] This goal can be achieved through the implementation of a control process to verify the integrity of a flexible package containing contents, including sterilized contents, the package comprising at least one porous film made of a porous material providing permeability for air molecules and a barrier to particles having dimensions greater than a limit value substantially equal to 0.5 pm, the control process comprising the following cycle of steps:
[0025] E2: diffusion of a gas under pressure having a pressure strictly greater than a pressure prevailing in an external environment outside the packaging, said diffusion being applied at the level of a diffusion zone of the porous film by a diffuser so as to cause the gas under pressure to penetrate inside the packaging through the porous film at the level of the diffusion zone and create a swelling of the porous film located outside the diffusion zone,
[0026] E3: evaluation, using a detection system, of a value taken by at least one physical quantity associated with said swelling, at the level of a control zone belonging to the porous film and distinct from the diffusion zone,
[0027] E4: Determination of the presence of an integrity defect outside the diffusion zone based on a comparison between the value evaluated in step E3 and a predetermined threshold, particularly if the value evaluated in step E3 is lower than said predetermined threshold. The process is fast, economical, safe, ergonomic, simple, and effective. The diffusion of pressurized gas inside the flexible packaging via the diffuser generates internal stresses on the packaging walls, particularly on the porous film, towards the external environment. By ensuring that the flexible packaging has the capacity to deform due to the expansion of its internal volume, these internal stresses cause deformation of the packaging walls, particularly the porous film, towards the external environment, which is physically manifested as swelling outside the diffusion zone.In cases where the external environment allows swelling through free deformation of the porous film outside the diffusion zone, the swelling can be characterized by a physical quantity corresponding to the displacement of the porous film (i.e., the total height of the swelling) in areas of free movement, particularly in the control zone. In cases where the external environment imposes limitations on how the porous film can deform, the swelling will exert thrust stresses on an element of the external environment. These thrust stresses can be quantified; in other words, the swelling can then be characterized by a physical quantity corresponding to the value of these thrust stresses, particularly in the control zone. The thrust stresses exerted are expected to increase as the pressurized gas diffuses.The thrust stresses or displacement therefore correspond to physical quantities associated with the diffusion of pressurized gas and its expansion, particularly within the control zone. The detection system, positioned within the control zone, allows, in step E3, the advantageous evaluation of the thrust stresses and / or displacement described above within the control zone during the diffusion of pressurized gas. Thus, it is possible to determine, in step E4, whether an integrity defect is present: if the predetermined threshold is exceeded by the thrust stresses and / or displacement within the control zone during the diffusion of pressurized gas, it can be considered that the packaging does not present an integrity defect outside the diffusion zone.However, during step E4, an integrity defect will be determined when the thrust forces and / or displacement at the control zone during the release of pressurized gas do not exceed the relevant predetermined threshold. Indeed, if the packaging has an integrity defect, then a quantity of pressurized gas escapes through it during release, thus preventing the predetermined threshold for displacement or thrust forces from being exceeded. Furthermore, the control process is advantageously non-destructive, as it requires no alteration of the flexible packaging for its implementation. This provides flexibility in implementation and makes the process applicable by the contents manufacturer. Moreover, the process has the advantage of being a manual or automated solution, allowing for the agile handling of both small and large quantities.Finally, the process prevents contamination of the inside of the packaging and its contents during the implementation of the control process.
[0028] Some preferred but not exhaustive aspects of this control process, which can be taken individually or in combination, are presented below.
[0029] The cycle includes a positioning step EO, implemented before steps E2 to E4, consisting of positioning the packaging and its contents in at least one counter-form, the counter-form comprising an imprint cut into a top face along a principal direction, the imprint being intended to allow at least partial insertion of the packaging at the EO step and the contents conforming to all or part of the shape of the imprint at the EO step, all or part of the packaging and its contents remaining partially inserted in the imprint along the principal direction during step E2 and the bulge protruding beyond the top face along the principal direction during step E2.
[0030] The counter-mold's shape holds the packaging and its contents in position, both transversely to the main direction and in the main direction towards the mold, during the diffusion of pressurized gas using the diffuser. The counter-mold prevents the packaging and its contents from being displaced by the pressure of the diffused gas in the two directions described above. Positioning the counter-mold within the mold maximizes the reproducibility of the inspection process.
[0031] The footprint corresponds dimensionally to at least part of the contents such that the EO step involves a substantially zero clearance of the packaging between the contents and the footprint.
[0032] An indentation whose dimensions correspond to those of the contents prevents the packaging from swelling in the principal direction, towards the indentation in step E2. Swelling can only occur in the principal direction on a side opposite the indentation. Such swelling results in a greater displacement of the porous film or greater thrust stresses in the control zone compared to swelling distributed throughout the entire package. The cycle includes a support step E1, implemented before step E2, consisting of applying pressure to the packaging in the control zone using at least one movable counter-support in the principal direction.
[0033] The counter-support on the packaging prevents the packaging and its contents from being ejected by the pressure of the gas diffused in the main direction. The counter-support also facilitates the detection of a change in a previously described physical quantity by the detection system.
[0034] Step E1 is implemented after step E0, the support implemented during step E1 being done in such a way that the counter-support presses on the packaging in the main direction towards the imprint of the counter-form at the level of the control area.
[0035] The positioning of the packaging and its contents in the counter-form, as well as the support of the counter-support on the packaging, prevents the latter and its contents from being evacuated by the pressure of the diffused gas by forcing them to remain in position.
[0036] The E3 evaluation step is carried out at the level of at least part of the counter-support along the main direction.
[0037] The thrust forces or displacement of the porous film at the control zone will be applied to the counter-support that rests on the packaging in that control zone. Thus, the counter-support can serve as an intermediary between the packaging and the detection system for step E3.
[0038] The cycle includes a withdrawal step E5, consisting of a withdrawal of the counter-support and diffuser from the packaging, with step E5 being implemented after step E4.
[0039] Removing the diffuser and the counter-support allows the packaging to be released to allow a new cycle to be performed.
[0040] At least one flexible material of the packaging, including porous film, is a non-woven, fibrous synthetic material, containing, for example, polyethylene fibers.
[0041] The non-woven, fibrous synthetic material is advantageously porous to allow the passage of pressurized gas while preventing the passage of contaminants such as heavy dust, soil particles, airborne dust, bacteria, microbes, and viruses.
[0042] The at least one physical quantity associated with swelling, the value of which is evaluated in step E3, includes a displacement of the porous film in the control zone, the detection system having a displacement measurement element, and in which the predetermined threshold is a minimum height.
[0043] Alternatively or in combination with the previous variant, at least one physical quantity associated with swelling, the value of which is evaluated in step E3, includes a pressure stress element belonging to the detection system, and in which the predetermined threshold is a minimum force.
[0044] The control process may include the following successive phases:
[0045] P1: Implementation of the cycle on the packaging,
[0046] P2: Turn the packaging over,
[0047] P3: implementation of the cycle on the packaging, so that the diffusion zone used in phase P1 is located outside the diffusion zone used in phase P3.
[0048] Phase P1 tests the integrity of the packaging outside the diffusion zone used during phase P1, while phase P3, which follows phase P1 after the inversion according to phase P2, tests the integrity of the packaging at least within the diffusion zone used during phase P1. The sequence of these phases ensures that there are no integrity defects in the packaging as a whole, which would not be possible by performing a single cycle.
[0049] The invention also relates to a control installation for implementing such a control method, the control installation comprising:
[0050] at least one diffuser capable of diffusing the gas under pressure, having a pressure strictly greater than the pressure prevailing in the external environment outside the packaging, at the level of the diffusion zone belonging to the porous film of the packaging, so as to allow the gas under pressure to penetrate inside the packaging through the porous film at the level of the diffusion zone so as to create a swelling of the porous film outside the diffusion zone,
[0051] a detection system capable of evaluating the value taken by at least one physical quantity associated with said swelling, at the level of the control zone belonging to the porous film and distinct from the diffusion zone.
[0052] The advantages of the control installation are identical to those presented for the control process.
[0053] Summary Description of Drawings: Other aspects, objectives, advantages, and features of the invention will become clearer upon reading the following detailed description of preferred embodiments thereof, given by way of non-limiting example, and made with reference to the accompanying drawings in which:
[0054] Figure 1 is a schematic view of an example of a control installation according to the invention, between steps E1 and E2.
[0055] Figure 2 represents the installation of figure 1, after the implementation of step E2.
[0056] Figure 3 illustrates a flowchart of the different steps of an example of a control process according to the invention.
[0057] Detailed description
[0058] In the figures and throughout the description, the same reference numerals represent identical or similar elements. Furthermore, the various elements are not drawn to scale to ensure clarity. Moreover, the different embodiments and variants are not mutually exclusive and can be combined.
[0059] Unless otherwise stipulated, the term "substantially" means, in this document, "exactly or to within 10% or to within 10° or to within 1 mm".
[0060] Figure 3 shows a possible embodiment for the sequence of steps of a cycle C of a non-limiting embodiment of a control method according to the invention, described below.
[0061] The example shown in Figure 1 illustrates a flexible package 110 containing a contents 120, specifically sterilized contents 120. This package 110 comprises a porous film 111 made of a porous material that is permeable to air molecules (with dimensions on the order of nanometers) and a barrier to particles larger than a limit value approximately equal to 0.5 pm. This package 110 may also include an impermeable film 112 made of an airtight material. Although the package 110 in the example of Figure 1 comprises a single porous film 111 complemented by the impermeable film, it could just as easily comprise two porous films forming a closed pouch, or even two pouches nested one inside the other.
[0062] In one embodiment, the cycle C includes a step E0 in which the package 110 and its contents 120 are positioned in a counter-mold 40. The counter-mold 40 comprises a cavity 43 cut into an upper face 42 along a principal direction A1. This step is illustrated in Figure 1, which shows a control installation with a package 110 and its contents 120 positioned in the cavity 43 of a single counter-mold 40. Although Figure 1 illustrates a single counter-mold 40, the number of counter-molds 40 may be equal to 2 or more, without distinction.
[0063] In Figure 1, it can be seen that the cavity 43 allows for the partial insertion of the package 110, but it could just as easily have allowed for its complete insertion. In the same Figure 1, the contents 120 fill the entire cavity 43, whereas they could perfectly well fill only a portion of it.
[0064] Figure 1 illustrates the fact that the footprint 43 corresponds dimensionally to the content 120, such that step E0 implies a substantially zero movement of the packaging 110 between the content 120 and the footprint 43.
[0065] In connection with Figure 3, cycle C also includes a step E1 of applying pressure to the packaging 110 at a designated control zone, labeled ZC. Figure 1 also shows the situation after this step E1. It can be seen that the pressure is applied to the porous film 111 of the packaging 110, but this could also have been the case on the impermeable film 112, for example.
[0066] Still on figure 1, we can see that the support is made in such a way that the counter-support 30 presses on the packaging 110 in the main direction A1 towards the imprint 43 of the counter-form 40, at the level of the control zone ZC.
[0067] In the embodiment of Figure 1, the control installation includes two separate counter-supports 30, but this is not limiting and the control installation could equally include only one counter-support 30.
[0068] As can be seen in Figure 3, cycle C also includes a step E2 of diffusion of a pressurized gas P having a pressure strictly greater than the pressure prevailing in an external environment outside the package 110. Figure 2 illustrates the control setup of Figure 1 after this diffusion step E2 has been implemented. The diffusion is applied by a diffuser 10 at a diffusion zone, labeled ZD, belonging to the porous film 111 and distinct from the control zone ZC. The parameters for this diffusion are chosen so as to allow the pressurized gas P to penetrate the package 110 through the porous film 111 at the diffusion zone ZD and to create a swelling of the porous film 111 located outside the diffusion zone ZD. In Figure 2, the swelling is located on the left side of the package 110.
[0069] By "external pressure prevailing outside the packaging", it is understood that the atmospheric pressure in which the control process is implemented. Preferably, the diffusion zone ZD involves an area corresponding to approximately one third of the total area of the packaging 110.
[0070] Figure 1 shows an initial distance G between the bottom of the indentation 43 and the control zone ZC, measured along the principal direction A1, before the implementation of step E2. Figure 2 illustrates a swelling distance G' between the bottom of the indentation 43 and the control zone ZC along the principal direction A1 during the implementation of step E2. The distance G is strictly less than the distance G' due to the swelling obtained during step E2 on the package 110.
[0071] Preferably, the control zone ZC is located in the other two-thirds of the surface of the package 110, that is to say outside the first third of the package 110 in which the diffusion zone ZD is located.
[0072] In the scenario illustrated in Figure 2, the package 110 is partially inserted into the cavity 43 along the principal direction A1 during step E2, while its contents 120 are fully inserted into the cavity 43, with the bulge protruding beyond the upper face 42 along the principal direction A1 during step E2. Alternatively, it would have been possible to have a configuration in which both the package 110 and the contents 120 are partially inserted into the cavity, or another configuration in which both the package 110 and the contents 120 are fully inserted into the cavity 43.
[0073] Referring to Figure 3, cycle C also includes a step E3 consisting of evaluating a value taken by at least one physical quantity associated with the previously mentioned swelling. This evaluation step E3 is implemented by a detection system 20 visible in Figures 1 and 2. This physical quantity associated with the swelling, such as a displacement of the porous film 111 at the swelling site or a mechanical stress (i.e., a force) applied by the porous film 111 at the swelling site, is evaluated by the appropriate detection system 20 at the control zone ZC already mentioned.
[0074] In one embodiment, the evaluation step E3 is carried out at the level of at least a part of the counter-support 30 along the main direction A1, as illustrated in Figure 2.
[0075] Referring now to Figure 3, cycle C also includes a step E4 consisting of determining the presence of an integrity defect 90 outside the diffusion zone ZD, based on a comparison between the value evaluated in step E3 and the predetermined threshold. In particular, the presence of an integrity defect 90 can be characterized if the value evaluated in step E3 is less than the predetermined threshold, which implies that the absence of an integrity defect 90 (thus implying that the integrity of the package 110 is guaranteed) is characterized if the value evaluated in step E3 is greater than or equal to the predetermined threshold.
[0076] As previously suggested, one alternative implementation of the control process may involve the physical quantity associated with swelling, the value of which is evaluated in step E3, including a displacement of the porous film within the control zone ZC. In this case, the detection system 20 may include a displacement measurement element, such as a probe or a comparator. The predetermined threshold is a minimum height to be reached, which is fixed in a reference frame linked to the counter-mold 40. Detection of exceeding the threshold can be automated or detected visually, either with the naked eye or using optical image or video recording devices. The minimum height to be reached can be predetermined, for example, based on the expected and predictable difference between the initial distance G and the swelling distance G'.
[0077] Alternatively, or in combination, another implementation variant of the control method may stipulate that the physical quantity associated with swelling, the value of which is evaluated in step E3, includes thrust stresses applied by the porous film 111 in the control zone ZC. In this case, the detection system 20 may include a stress measurement element, such as a load cell capable of measuring compressive force or any other equivalent means. The predetermined threshold is then a minimum force to be achieved.
[0078] As illustrated in Figure 3, cycle C is such that step E4 is followed by step E5 consisting of a withdrawal of the counter-support 30 and the diffuser 10 from the packaging 110. This step is implemented once the inspection has been carried out and before a new inspection can be carried out on a new package.
[0079] Even though it is possible (in a degraded variant) to provide that cycle C is implemented only once for a given package 110, in a preferred embodiment, the control process may include the following successive phases:
[0080] - P1: Implementation of cycle C on packaging 110,
[0081] - P2: Turning over packaging 110,
[0082] - P3: Implementation of cycle C on the package 110, such that the diffusion zone ZD used in phase P1 is located outside the diffusion zone ZD used in phase P3. When the presence of an integrity defect 90 is determined in step E4 of cycle C of phase P1, then it is not necessary to implement phases P2 and P3, which provide no added value and are therefore superfluous. The package 110 and its contents 120 can be discarded directly after phase P1.
[0083] When the presence of an integrity defect 90 is not determined during step E4 of cycle C of phase P1, but an integrity defect is subsequently determined during step E4 of phase P3, this means that the package 110 had an integrity defect 90 at the diffusion zone ZD used in step E2 of phase P1 that could not be detected during phase P1. This is because the diffusion of the pressurized gas P at the diffusion zone ZD may have prevented the leakage of pressurized gas P through this integrity defect 90, since pressurized gas P entered the package 110 through it. In this case, the package 110 and its contents 120 can be discarded after phase P3.
[0084] Finally, if no integrity defect 90 is detected during phases P1 and P3, then the packaging 110 and its contents 120 can be considered to meet the integrity criterion and are valid. They can be shipped or used.
[0085] According to a preferred embodiment, diffusion at step E2 of phase P1 takes place in the diffusion zone ZD, belonging to a first third on the side of a first end of the package 110, while diffusion at step E2 of phase P3 takes place outside the diffusion zone ZD, at the level of another third on the side of a second end of the package 110.
[0086] In one scenario, a flexible packaging material 110, in particular porous film 111, is a non-woven, fibrous synthetic material, containing, for example, polyethylene fibers.
[0087] In other words, in one embodiment, the packaging can be made entirely or partly of Tyvek®, which makes it possible to provide a porous material with pores having dimensions between 0.5 and 10 microns, which is suitable for the desired function of permeability to air molecules and impermeability to particles having dimensions greater than or equal to 0.5 microns.
Claims
DEMANDS 1. A testing method (100) for checking the integrity of a flexible package (110) containing a content (120), in particular a sterilized content (120), the package (110) comprising at least one porous film (111) made of a porous material conferring permeability to air molecules and a barrier to particles having dimensions greater than a limit value substantially equal to 0.5 pm, the testing method (100) comprising the cycle (C) of the following steps: E2: diffusion of a pressurized gas (P) having a pressure strictly greater than a pressure prevailing in an external environment outside the packaging (110), said diffusion being applied at the level of a diffusion zone (ZD) of the porous film (111) by a diffuser (10) so as to cause the pressurized gas (P) to penetrate inside the packaging (110) through the porous film (111) at the level of the diffusion zone (ZD) and create a swelling of the porous film (111) located outside the diffusion zone (ZD), E3: evaluation, by means of a detection system (20), of a value taken by at least one physical quantity associated with said swelling, at the level of a control zone (CZ) belonging to the porous film (111) and distinct from the diffusion zone (DZ), E4: determination of the presence of an integrity defect (90) outside the diffusion zone (DZ) based on a comparison between the value evaluated in step E3 and a predetermined threshold, in particular if the value evaluated in step E3 is lower than said predetermined threshold.
2. A testing method (100) according to claim 1, wherein the cycle (C) comprises a positioning step E0, carried out before steps E2 to E4, consisting of positioning the package (110) and its contents (120) in at least one counter-mold (40), the counter-mold (40) comprising an indentation (43) cut into an upper face (42) along a principal direction (A1), the indentation (43) being intended to allow at least partial insertion of the package (110) in step E0 and the contents (120) conforming to all or part of the shape of the indentation (43) in step E0, all or part of the package (110) and its contents (120) remaining partially inserted in the indentation (43) along the principal direction (A1) during step E2 and the bulge protruding beyond the upper face (42) along the principal direction (A1) during step E2.3.Control method (100) according to claim 2, wherein the indentation (43) corresponds dimensionally to at least a part of the contents (120) such that step E0 involves a substantially zero movement of the packaging (110) between the contents (120) and the indentation (43).
4. Control method (100) according to any one of the preceding claims, wherein the cycle (C) includes a support step E1, implemented before step E2, consisting of a support on the packaging (110) at the level of the control zone (ZC) by means of at least one counter-support (30) movable in the main direction (A1).
5. Control method (100) according to claims 2 and 4, wherein step E1 is carried out after step E0, the support carried out during step E1 being done so that the counter-support (30) presses on the packaging (110) in the main direction (A1) towards the imprint (43) of the counter-form (40) at the level of the control zone (ZC).
6. Control method (100) according to claim 5, wherein the evaluation step E3 is carried out at the level of at least a part of the counter support (30) along the main direction (A1).
7. Control method (100) according to any one of claims 4 to 6, wherein the cycle (C) includes a withdrawal step E5, consisting of a withdrawal of the counter-support (30) and the diffuser (10) from the packaging (110), step E5 being carried out after step E4.
8. Control method (100) according to any one of the preceding claims, wherein at least one flexible material of the packaging (110), in particular of the porous film (111), is a synthetic non-woven and fibrous material, containing for example polyethylene fibers.
9. A control method (100) according to any one of the preceding claims, wherein at least one physical quantity associated with swelling, the value of which is evaluated in step E3, comprises a displacement of the porous film in the control zone (ZC), the detection system (20) having a displacement measuring element, and wherein the predetermined threshold is a minimum height.
10. A control method (100) according to any one of the preceding claims, wherein at least one physical quantity associated with swelling, the value of which is evaluated in step E3, comprises thrust stresses applied by the porous film (111) in the control zone (ZC), a stress measuring element belonging to the detection system, and wherein the predetermined threshold is a minimum force.
11. A control method (100) according to any one of the preceding claims, comprising the following successive steps: - P1: implementation of cycle (C) on the packaging (110), P2: Turning the packaging over (110), P3: implementation of cycle (C) on the packaging (110), so that the diffusion zone (ZD) used in phase P1 is located outside the diffusion zone (ZD) used in phase P3.
